5yr
Cost-effectiveness of Erenumab Versus Surgical Trigger Site Deactivation for the Treatment of Migraine Headaches: A Systematic Review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33710044/
doi: 10.1097/SCS.0000000000007617. Online ahead of print. 1 Northwestern University Feinberg School of Medicine, Chicago, IL Department of Plastic Surgery Department of Neurology, University of California, Irvine School of Medicine, Orange, CA. doi: 10.1097/SCS.0000000000007617. Online ahead of print. 1 Northwestern University Feinberg School of Medicine, Chicago, IL Department of Plastic Surgery Department of Neurology, University of California, Irvine School of Medicine, Orange, CA.
1. The data to support surgical trigger site deactivation for migraine is quite limited and biased
2. The estimates for the direct cost for episodic and chronic migraine were quite a large range and higher than those that I have seen in the past
3. Even with surgical treatment, there are still annual direct costs because these individuals do not become headache free
Therefore, I would hope that this article does not convince providers to consider an invasive and marginally effective therapy such as surgery without trying well established effective, well tolerated medical treatments such as CGRP mab